[Neuropsychiatric disorders induced by exposure to metals].
Matsuoka
Masato
M
Department of Environmental Toxicology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health.
Igisu
Hideki
H
D000535:Aluminum / Q000009:adverse effects* / Q000493:pharmacokinetics; D002614:Chelating Agents / Q000627:therapeutic use; D006801:Humans; D007854:Lead / Q000009:adverse effects* / Q000493:pharmacokinetics; D008345:Manganese / Q000009:adverse effects* / Q000493:pharmacokinetics; D001523:Mental Disorders / Q000139:chemically induced* / Q000628:therapy; D008628:Mercury / Q000009:adverse effects* / Q000493:pharmacokinetics; D009942:Organometallic Compounds / Q000009:adverse effects / Q000493:pharmacokinetics; D006435:Renal Dialysis
D002614:Chelating Agents; D009942:Organometallic Compounds; D007854:Lead; D008345:Manganese; D000535:Aluminum; D008628:Mercury